GENE ONLINE|News &
Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer
Cocrystal Pharma announced on Wednesday the appointment of James Sapirstein as the company’s new Chief Executive Officer. Sapirstein, a veteran of the biopharmaceutical industry, brings experience in the development of antiviral medications to the leadership role.
The company selected Sapirstein to oversee its ongoing operations and strategic initiatives regarding its antiviral drug pipeline. His professional background includes executive roles at various biopharmaceutical firms, where he focused on the clinical development and commercialization of therapeutic treatments. Cocrystal Pharma confirmed the leadership transition effective immediately, as the organization continues its research and development efforts in the antiviral sector.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 3, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
